Raymond Stapleton

Raymond Stapleton

Chief Tech/Sci/R&D Officer chez VAXART, INC.

Health Technology
Consumer Services
Commercial Services

Profil

Raymond D.
Stapleton
is currently the President & Chief Operating Officer at International BioResources Group and the Chief Technology Officer at Vaxart, Inc. He was previously the Executive Director-Global Vaccine Technology at Merck & Co., Inc., the President & Chief Operating Officer at American Type Culture Collection, the Chief Technology Officer & Executive VP at Genocea Biosciences, Inc., and the Senior Vice President-Manufacturing at Theriva Biologics, Inc. He also briefly served as the Senior Vice President-Technical Operations at Iovance Biotherapeutics, Inc. Stapleton holds a doctorate from the University of Tennessee and an undergraduate degree from the University of Mary Washington.

Postes actifs de Raymond Stapleton

SociétésPosteDébut
VAXART, INC. Chief Tech/Sci/R&D Officer 31/08/2022
President -
Tous les postes actifs de Raymond Stapleton

Anciens postes connus de Raymond Stapleton

SociétésPosteFin
President 01/01/2021
IOVANCE BIOTHERAPEUTICS, INC. Corporate Officer/Principal 01/11/2019
THERIVA BIOLOGICS, INC. Corporate Officer/Principal 01/07/2019
GENOCEA BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer -
MERCK & CO., INC. Corporate Officer/Principal -
Voir l'expérience en détail de Raymond Stapleton

Formation de Raymond Stapleton

University of Tennessee Doctorate Degree
University of Mary Washington Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Raymond Stapleton

Relations

29

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
MERCK & CO., INC.

Health Technology

GENOCEA BIOSCIENCES, INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

VAXART, INC.

Health Technology

Entreprise privées2

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Raymond Stapleton